Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics

Aishwarya Vijay; Ravi Gupta; Patrick Liu; Sanket S. Dhruva; Nilay D. Shah; Joseph S. Ross

doi:10.1007/s11606-019-05432-6

Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics

Aishwarya Vijay, Ravi Gupta, Patrick Liu, Sanket S. Dhruva, Nilay D. Shah, Joseph S. Ross

Quantitative Health Sciences

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1928-1930
Number of pages	3
Journal	Journal of general internal medicine
Volume	35
Issue number	6
DOIs	https://doi.org/10.1007/s11606-019-05432-6
State	Published - Jun 1 2020

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.1007/s11606-019-05432-6

Cite this

@article{f9059a6173b645de8dc2c5ddf0156e42,

title = "Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics",

author = "Aishwarya Vijay and Ravi Gupta and Patrick Liu and Dhruva, {Sanket S.} and Shah, {Nilay D.} and Ross, {Joseph S.}",

note = "Funding Information: In the past 36 months, Dr. Shah received research support through Mayo Clinic from the Food and Drug Administration to establish Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program (U01FD005938); the Centers of Medicare and Medicaid Innovation under the Transforming Clinical Practice Initiative (TCPI); the Agency for Healthcare Research and Quality (R01HS025164; R01HS025402; R03HS025517); the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) (R56HL130496; R01HL131535); the National Science Foundation; and the Patient Centered Outcomes Research Institute (PCORI) to develop a Clinical Data Research Network (LHSNet); Dr. Ross received research support through Yale University from Johnson and Johnson to develop methods of clinical trial data sharing, from Medtronic, Inc. and the Food and Drug Administration (FDA) to develop methods for postmarket surveillance of medical devices (U01FD004585), from the Food and Drug Administration to establish Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program (U01FD005938), from the Blue Cross Blue Shield Association to better understand medical technology evaluation, from the Centers of Medicare and Medicaid Services (CMS) to develop and maintain performance measures that are used for public reporting (HHSM-500-2013-13018I), from the Agency for Healthcare Research and Quality (R01HS022882), from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) (R01HS025164), and from the Laura and John Arnold Foundation to establish the Good Pharma Scorecard at Bioethics International and the Collaboration on Research Integrity and Transparency (CRIT) at Yale; all remaining authors declare no potential competing interests. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. ",

year = "2020",

month = jun,

day = "1",

doi = "10.1007/s11606-019-05432-6",

language = "English (US)",

volume = "35",

pages = "1928--1930",

journal = "Journal of general internal medicine",

issn = "0884-8734",

publisher = "Springer New York",

number = "6",

}

TY - JOUR

T1 - Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics

AU - Vijay, Aishwarya

AU - Gupta, Ravi

AU - Liu, Patrick

AU - Dhruva, Sanket S.

AU - Shah, Nilay D.

AU - Ross, Joseph S.

N1 - Funding Information: In the past 36 months, Dr. Shah received research support through Mayo Clinic from the Food and Drug Administration to establish Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program (U01FD005938); the Centers of Medicare and Medicaid Innovation under the Transforming Clinical Practice Initiative (TCPI); the Agency for Healthcare Research and Quality (R01HS025164; R01HS025402; R03HS025517); the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) (R56HL130496; R01HL131535); the National Science Foundation; and the Patient Centered Outcomes Research Institute (PCORI) to develop a Clinical Data Research Network (LHSNet); Dr. Ross received research support through Yale University from Johnson and Johnson to develop methods of clinical trial data sharing, from Medtronic, Inc. and the Food and Drug Administration (FDA) to develop methods for postmarket surveillance of medical devices (U01FD004585), from the Food and Drug Administration to establish Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program (U01FD005938), from the Blue Cross Blue Shield Association to better understand medical technology evaluation, from the Centers of Medicare and Medicaid Services (CMS) to develop and maintain performance measures that are used for public reporting (HHSM-500-2013-13018I), from the Agency for Healthcare Research and Quality (R01HS022882), from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) (R01HS025164), and from the Laura and John Arnold Foundation to establish the Good Pharma Scorecard at Bioethics International and the Collaboration on Research Integrity and Transparency (CRIT) at Yale; all remaining authors declare no potential competing interests. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

PY - 2020/6/1

Y1 - 2020/6/1

UR - http://www.scopus.com/inward/record.url?scp=85074503778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074503778&partnerID=8YFLogxK

U2 - 10.1007/s11606-019-05432-6

DO - 10.1007/s11606-019-05432-6

M3 - Article

C2 - 31625043

AN - SCOPUS:85074503778

SN - 0884-8734

VL - 35

SP - 1928

EP - 1930

JO - Journal of general internal medicine

JF - Journal of general internal medicine

IS - 6

ER -

Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this